Cargando…

Expression of ATF6 as a marker of pre-cancerous atypical change in ulcerative colitis-associated colorectal cancer: a potential role in the management of dysplasia

BACKGROUND: Diagnosis of low-grade dysplasia (LGD) is important in the management of ulcerative colitis (UC), but it is often difficult to distinguish LGD from inflammatory regenerative epithelium. The unfolded protein response (UPR) is activated in inflammatory bowel disease and malignancies. We ai...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hanaoka, Marie, Ishikawa, Toshiaki, Ishiguro, Megumi, Tokura, Michiyo, Yamauchi, Shinichi, Kikuchi, Akifumi, Uetake, Hiroyuki, Yasuno, Masamichi, Kawano, Tatsuyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Japan 2017
Materias:	Original Article—Alimentary Tract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5910497/ https://www.ncbi.nlm.nih.gov/pubmed/28884228 http://dx.doi.org/10.1007/s00535-017-1387-1

Ejemplares similares

Selective expansion of intraepithelial lymphocytes expressing the HLA-E–specific natural killer receptor CD94 in celiac disease()()
por: Jabri*, ‡, §, Bana, et al.
Publicado: (2000)

Clinical characteristics of coronavirus disease (COVID-19) patients with gastrointestinal symptoms: A report of 164 cases
por: Zhang, Hu, et al.
Publicado: (2020)

COVID-19 pandemic perception in adults with celiac disease: an impulse to implement the use of telemedicine
por: Siniscalchi, Monica, et al.
Publicado: (2020)

Impact of COVID-19 outbreak on clinical practice and training of young gastroenterologists: A European survey
por: Marasco, Giovanni, et al.
Publicado: (2020)

COVID-19 in IBD: The experience of a single tertiary IBD center
por: Rizzello, Fernando, et al.
Publicado: (2021)

Impact of the COVID-19 outbreak and the serum prevalence of SARS-CoV-2 antibodies in patients with inflammatory bowel disease treated with biologic drugs
por: Bossa, Fabrizio, et al.
Publicado: (2021)

Risk of COVID 19 in patients with inflammatory bowel diseases compared to a control population
por: Maconi, Giovanni, et al.
Publicado: (2021)

Maintaining standard volumes, efficacy and safety, of fecal microbiota transplantation for C. difficile infection during the COVID-19 pandemic: A prospective cohort study
por: Ianiro, Gianluca, et al.
Publicado: (2020)

Anti-SARS-CoV-2 immunoglobulin profile in patients with celiac disease living in a high incidence area
por: Elli, Luca, et al.
Publicado: (2022)

Impact of COVID-19 pandemic on the management of paediatric inflammatory bowel disease: An Italian multicentre study on behalf of the SIGENP IBD Group
por: Arrigo, Serena, et al.
Publicado: (2021)

Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease: Data from ESCAPE-IBD, an IG-IBD study
por: Macaluso, Fabio Salvatore, et al.
Publicado: (2023)

The natural history of COVID-19 in vaccinated inflammatory bowel disease patients
por: Viazis, N., et al.
Publicado: (2023)

PHLDA1 expression in ulcerative colitis: A potential role in the management of dysplasia
por: Orita, Fukuichiro, et al.
Publicado: (2021)

Retinoic acid receptor γ activation promotes differentiation of human induced pluripotent stem cells into esophageal epithelium
por: Koterazawa, Yasufumi, et al.
Publicado: (2020)

Mucin Gene Deficiency in Mice Impairs Host Resistance to an Enteric Parasitic Infection
por: Hasnain, Sumaira Z., et al.
Publicado: (2010)

IL23R Variation Determines Susceptibility But Not Disease Phenotype in Inflammatory Bowel Disease
por: Tremelling, Mark, et al.
Publicado: (2007)

Tissue-Specific Amino Acid Transporter Partners ACE2 and Collectrin Differentially Interact With Hartnup Mutations
por: Camargo, Simone M.R., et al.
Publicado: (2009)

Multicenter prospective in vivo study of an endocytoscope system (ECS) for superficial esophageal cancer
por: Morita, Shuko, et al.
Publicado: (2021)

Clinical impact of intratumoral HER2 heterogeneity on trastuzumab efficacy in patients with HER2-positive gastric cancer
por: Wakatsuki, Takeru, et al.
Publicado: (2018)

The clonal heterogeneity of colon cancer with liver metastases
por: Chen, Guanxuan, et al.
Publicado: (2023)

Excess weight among colorectal cancer survivors: target for intervention
por: Soerjomataram, I., et al.
Publicado: (2012)

The impact of the COVID-19 pandemic on the diagnosis, stage, and treatment of esophagogastric cancer
por: Doeve, Benthe H., et al.
Publicado: (2023)

Risk of gastric cancer in the second decade of follow-up after Helicobacter pylori eradication
por: Take, Susumu, et al.
Publicado: (2019)

Mortality and cancer in eosinophilic gastrointestinal disorders distal to the esophagus: nationwide cohort study 1990–2017
por: Bledsoe, Adam C., et al.
Publicado: (2022)

Genomic landscape of epithelium with low-grade atypia on gastric cancer after Helicobacter pylori eradiation therapy
por: Masuda, Kazuhiko, et al.
Publicado: (2019)

Physician–patient communication affects patient satisfaction in treatment decision-making: a structural equation modelling analysis of a web-based survey in patients with ulcerative colitis
por: Matsuoka, Katsuyoshi, et al.
Publicado: (2021)

Aberrant methylation of microRNA-34b/c is a predictive marker of metachronous gastric cancer risk
por: Suzuki, Ryo, et al.
Publicado: (2013)

Identification of differentially expressed signatures of long non-coding RNAs associated with different metastatic potentials in gastric cancer
por: Song, Wu, et al.
Publicado: (2015)

The tumor-stromal ratio as a strong prognosticator for advanced gastric cancer patients: proposal of a new TSNM staging system
por: Peng, Chunwei, et al.
Publicado: (2017)

Combination treatment with highly bioavailable curcumin and NQO1 inhibitor exhibits potent antitumor effects on esophageal squamous cell carcinoma
por: Mizumoto, Ayaka, et al.
Publicado: (2019)

Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term non-steroidal anti-inflammatory drug (NSAID) therapy: results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled trial
por: Sugano, Kentaro, et al.
Publicado: (2012)

miR-324-3p promotes gastric cancer development by activating Smad4-mediated Wnt/beta-catenin signaling pathway
por: Sun, Guang-Li, et al.
Publicado: (2017)

Age at diagnosis of inflammatory bowel disease influences early development of colorectal cancer in inflammatory bowel disease patients: a nationwide, long-term survey
por: Baars, J. E., et al.
Publicado: (2012)

Transcriptomic expression profiling identifies ITGBL1, an epithelial to mesenchymal transition (EMT)-associated gene, is a promising recurrence prediction biomarker in colorectal cancer
por: Matsuyama, Takatoshi, et al.
Publicado: (2019)

Methylation of bone morphogenetic protein 2 is associated with poor prognosis in colorectal cancer
por: Miura, Tomiyuki, et al.
Publicado: (2020)

Endoscopic evaluation by the Kyoto classification of gastritis combined with serum anti-Helicobacter pylori antibody testing reliably risk-stratifies subjects in a population-based gastric cancer screening program
por: Hirai, Ryosuke, et al.
Publicado: (2023)

NUDT15 codon 139 is the best pharmacogenetic marker for predicting thiopurine-induced severe adverse events in Japanese patients with inflammatory bowel disease: a multicenter study
por: Kakuta, Yoichi, et al.
Publicado: (2018)

The effectiveness of plasma miR-33a-5p as a predictive biomarker for the efficacy of colorectal cancer chemotherapy
por: Sasaki, Megumi, et al.
Publicado: (2021)

Expert consensus on vaccination in patients with inflammatory bowel disease in Japan
por: Ishige, Takashi, et al.
Publicado: (2023)

A nationwide survey concerning the mortality and risk of progressing severity due to arterial and venous thromboembolism in inflammatory bowel disease in Japan
por: Ando, Katsuyoshi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_k2encu2s4p2j4rkamm3fqtd2ag